Skip to main content

01-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The JAVELIN Bladder 100 trial

Thomas Powles discusses the phase 3 trial investigating the use of maintenance avelumab after first-line chemotherapy in patients with advanced urothelial cancer (6:19).

Read transcript

Have your say on Medicine Matters

Visit the conference hub

Image Credits